Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Net Income towards Common Stockholders (2020 - 2025)

Cytek Biosciences (CTKB) has disclosed Net Income towards Common Stockholders for 6 consecutive years, with -$44.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Income towards Common Stockholders fell 557.13% year-over-year to -$44.1 million, compared with a TTM value of -$66.5 million through Dec 2025, down 1005.3%, and an annual FY2025 reading of -$66.5 million, down 1005.3% over the prior year.
  • Net Income towards Common Stockholders was -$44.1 million for Q4 2025 at Cytek Biosciences, down from -$5.5 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $9.6 million in Q4 2024 and bottomed at -$44.1 million in Q4 2025.
  • Average Net Income towards Common Stockholders over 5 years is -$4.2 million, with a median of -$2.0 million recorded in 2022.
  • Peak annual rise in Net Income towards Common Stockholders hit 381.5% in 2022, while the deepest fall reached 2081.37% in 2022.
  • Year by year, Net Income towards Common Stockholders stood at $346000.0 in 2021, then skyrocketed by 919.94% to $3.5 million in 2022, then skyrocketed by 55.94% to $5.5 million in 2023, then surged by 75.21% to $9.6 million in 2024, then plummeted by 557.13% to -$44.1 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for CTKB at -$44.1 million in Q4 2025, -$5.5 million in Q3 2025, and -$5.6 million in Q2 2025.